---
figid: PMC12061301__ADVS-12-2408106-g005
figtitle: AKT1 regulating cuproptosis in TNBC tumorigenesis
organisms:
- NA
organisms_ner:
- Homo sapiens
- Danio rerio
pmcid: PMC12061301
filename: ADVS-12-2408106-g005.jpg
figlink: /pmc/articles/PMC12061301/figure/F7/
number: F7
caption: Model of AKT1 regulating cuproptosis in TNBC tumorigenesis. Schematic illustration
  of AKT1 role in regulating cuproptosis. Copper activates AKT signaling pathway,
  which inhibits cuproptosis by directly phosphorylating ferredoxin‐1 (FDX1), a key
  regulator of cuproptosis. AKT‐mediated FDX1 phosphorylation not only abrogates FDX1‐induced
  cuproptosis and aerobic respiration, but also promotes glycolysis. Consequently,
  combination of the AKT inhibitor MK2206 and the copper ionophore elesclomol synergistically
  induces cuproptosis and inhibits glycolysis, suggesting a feasible and effective
  therapeutic strategy for TNBC
papertitle: AKT1 Phosphorylates FDX1 to Promote Cuproptosis Resistance in Triple‐Negative
  Breast Cancer
reftext: Zicheng Sun, et al. Adv Sci (Weinh). 2025 May;12(17).
year: '2025'
doi: 10.1002/advs.202408106
journal_title: Advanced Science
journal_nlm_ta: Adv Sci (Weinh)
publisher_name: Wiley
keywords: AKT1 | breast cancer | cuproptosis | FDX1 | metabolic reprogramming
automl_pathway: 0.9442584
figid_alias: PMC12061301__F7
figtype: Figure
redirect_from: /figures/PMC12061301__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC12061301__ADVS-12-2408106-g005.html
  '@type': Dataset
  description: Model of AKT1 regulating cuproptosis in TNBC tumorigenesis. Schematic
    illustration of AKT1 role in regulating cuproptosis. Copper activates AKT signaling
    pathway, which inhibits cuproptosis by directly phosphorylating ferredoxin‐1 (FDX1),
    a key regulator of cuproptosis. AKT‐mediated FDX1 phosphorylation not only abrogates
    FDX1‐induced cuproptosis and aerobic respiration, but also promotes glycolysis.
    Consequently, combination of the AKT inhibitor MK2206 and the copper ionophore
    elesclomol synergistically induces cuproptosis and inhibits glycolysis, suggesting
    a feasible and effective therapeutic strategy for TNBC
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PDK1
  - PDPK1
  - AKT1
  - AKT2
  - AKT3
  - FDX1
  - DLAT
  - pdk1
  - fdx1
  - dlat
  - TCA
---
